New lung navigation system aims for precise nodule marking

NCT ID NCT07180823

Recruiting now Disease control Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests a new navigation system called LungVision to help doctors mark suspicious lung nodules before surgery. The system uses augmented fluoroscopy and ultrasound to guide a small marker to the nodule. The goal is to make marking easier and less invasive than current methods, allowing surgeons to remove the nodule completely while saving healthy lung tissue. The study will include 5 adults with partially solid lung nodules.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LungVision navigation system (device)
What this could lead to: If successful, this could make lung nodule marking safer and more accurate, allowing surgeons to remove cancerous nodules with smaller incisions and preserve more healthy lung tissue.
What could go wrong: This is a very small early study with only 5 participants, so results may not apply to everyone. The procedure still carries risks like lung collapse or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITING

Bologna, Bologna, 40138, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.